Sweeper’s lung disease: a cross-sectional study of an overlooked illness among sweepers of Pakistan
Shaikh Khurshid Anwar, Naeem Mehmood, Nasir Nasim, Maryam Khurshid, Bilal Khurshid
Department of Pulmonary Medicine, Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan
Background: Sweepers are prone to develop chronic obstructive pulmonary disease even without tobacco smoking.
Purpose: To investigate roadside dust as a cause of air flow obstruction among sweepers, and the role of spirometry in its preclinical diagnosis.
Material and methods: One-hundred nonsmoking sweepers (aged 30–60 years) of both sexes sweeping on roads for 8–12 hours a day for the Capital Development Authority of Islamabad, Pakistan were used as study participants (Group A). One-hundred healthy nonsmokers (aged 30–60 years) in the same socioeconomic group and living in the same environment represented the nonsweeper group (Group B). After proper clinical evaluation and chest X-rays, spirometric evaluation was carried out in both groups. Comparisons were drawn between various spirometric parameters.
Results: Pulmonary function tests showed that the mean forced vital capacity was 78 ± 1.40 in the sweeper group (Group A) and 83 ± 0.86 in the nonsweeper group (Group B). Mean forced expiratory volume in 1 second was 66 ± 1.67 in Group A and 85 ± 0.85 in Group B (P < 0.05), a difference of 19%. The forced midexpiratory flow was 41% lower in Group A than in Group B (P < 0.0001). The pattern of pulmonary function obstruction was shown to be proportional to the duration of exposure to dust caused by sweeping.
Conclusion: Occupational exposure to dust leads to an obstructive pattern among sweepers. Spirometry is the simplest, noninvasive technique to detect preclinical disease.
Keywords: COPD, sweepers, dust, spirometry
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Readers of this article also read:
The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes
Ye YJ, Wang Y, Lou KY, Chen YZ, Chen R, Gao F
Published Date: 3 July 2015
Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles
Wang B, Tan L, Deng D, Lu T, Zhou C, Li Z, Tang Z, Wu Z, Tang H
Published Date: 8 May 2015
Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease
Asai K, Kobayashi A, Makihara Y, Johnson M
Published Date: 17 April 2015
Dynamic hyperinflation and dyspnea during the 6-minute walk test in stable chronic obstructive pulmonary disease patients
Satake M, Shioya T, Uemura S, Takahashi H, Sugawara K, Kasai C, Kiyokawa N, Watanabe T, Sato S, Kawagoshi A
Published Date: 17 January 2015
Stability of refrigerated miglustat after preparation in InOrpha® flavored suspending excipient for compounding of oral solutions and suspensions
Riahi S, AmbΓΌhl M, Stichler J, Bandilla D
Published Date: 17 January 2015
The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease
Decramer ML, Hanania NA, Lötvall JO, Yawn BP
Published Date: 25 January 2013
Martin C, Frija J, Burgel PR
Published Date: 4 January 2013
Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, Zhang L, Wu H, Zhao J, Chen N
Published Date: 20 December 2012
Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease
Franssen FME, Spruit MA, Wouters EFM
Published Date: 26 September 2011
Rahul G Sangani, Andrew J Ghio
Published Date: 10 March 2011